In a climate of shrinking margins, diminishing reimbursement, and frequent denials, healthcare organizations may make efforts to increase the volume of services they provide, especially.
CMS Can Fix Medicare Vaccine Coverage To Protect Seniors From RSV healthaffairs.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthaffairs.org Daily Mail and Mail on Sunday newspapers.
MOULTRIE, Ga. — Alzheimer’s disease and other dementias are devastating. On Jan. 6, the U.S. Food and Drug Administration approved a medication that offers hope to those with Alzheimer s.
A new Optum report highlighting upcoming medications in the drug pipeline is meant as a heads-up for payers as they track developments with a couple of therapies for Alzheimer's disease – lecanemab and donanemab. Lecanemab, from Eisai/Biogen, is under review for the treatment of mild cognitive impairment (MCI) due to Alzheimer's disease. It's an antibody that binds to